Objective
Hypercholesterolemia (HC) and hypertension (HT) are associated with aortic valve stenosis (AVS) in humans. We have examined aortic valve function, structure, and gene expression in HC/HT mice.
Approach and Results
Control, hypertensive (HT), hypercholesterolemic (Apoe−/−) (HC), and HC/HT mice were studied. Severe aortic stenosis (echocardiography) occurred only in HC/HT mice. There was minimal calcification of the aortic valve. Several structural changes were identified at the base of the valve. The intercusp raphe (or “seam” between leaflets) was longer in HC/HT mice than in other mice, and collagen fibers at the base of the leaflets were reoriented to form a mesh. In HC/HT mice, the cusps were asymmetrical, which may contribute to changes that produce AVS. RNA-Sequencing (RNA-Seq) was used to identify molecular targets during the developmental phase of stenosis. Genes related to structure of the valve were identified that differentially expressed before FAVS developed. Both RNA and protein of a profibrotic molecule, plasminogen activator inhibitor 1 (PAI-1), were increased greatly in HC/HT mice.
Conclusions
HC/HT mice are the first model of fibrotic AVS. HC/HT mice develop severe AVS in the absence of significant calcification, a feature which resembles AVS in children and some adults. Structural changes at the base of the valve leaflets include lengthening of the raphe, remodeling of collagen, and asymmetry of the leaflets. Genes were identified that may contribute to development of FAVS.